Candidate

Loading…

Evidence-firstADMET-AI model evidenceAiZynthFinder route searchNo fabricated yield / priceExperimental confirmation required

Evidence Passport

Every populated result is measured, computed, retrieved or reviewed. Missing work stays visibly untested, unsearched, unrun or unassessed.

Loading passport…

Evidence ledger

Immutable evidence records linked to this candidate, with method/source provenance and record hashes.

Loading ledger…

Pre-CRO readiness

Run real model-based developability and real retrosynthetic search before deciding whether a computational hit is worth medicinal-chemistry/CRO review.

Loading readiness…

Scientific boundary: ADMET-AI outputs are pretrained-model predictions, not assays. AiZynthFinder routes are search hypotheses; route score is not synthesis-success probability. Yield, conditions, supplier price and CRO lead time are never invented.

Novelty & IP evidence

Search chemical identity/similarity and, when configured, EPO patent bibliographic evidence. Results do not establish patentability or FTO.

Patentability: NOT DETERMINED
Freedom to operate: NOT DETERMINED

Absence of an exact hit is not proof of novelty. Markush and claim scope require qualified legal review.

Patent / target query (optional)

Hit Review & Promotion

Human review advances the candidate to the next evidence stage only. It never labels the molecule experimentally validated.

Decision

Reviewer

Rationale